Todd Harris, Head of Corporate Development at Sienna Biopharmaceuticals, Inc. (SNNA), sold 33,821 shares at $20.09 ($679K) on 2018-04-18, disclosed to the SEC on 2018-04-19.
Open-market sale of $679k SNNA by Head of Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 2,201 | $44K | 6.5% |
| 2 | $20.09 | 15,810 | $318K | 46.8% |
| 3 | $20.09 | 15,810 | $318K | 46.8% |
| Total | $20.08 avg | 33,821 | $679K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |